{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:26:50Z","timestamp":1779204410532,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10517-018-4233-4","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T04:58:37Z","timestamp":1537160317000},"page":"649-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antidiabetic Activity of Afobazole in Wistar Rats"],"prefix":"10.1007","volume":"165","author":[{"given":"R. U.","family":"Ostrovskaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. V.","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. V.","family":"Voronin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. V.","family":"Ozerova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. N.","family":"Zolotov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. B.","family":"Seredenin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"issue":"2","key":"4233_CR1","first-page":"3","volume":"80","author":"EV Abramova","year":"2017","unstructured":"Abramova EV, Voronin MV, Seredenin SB. Radioligand Binding Assay of Sigma-1 Receptors in P2 and P3 Brain Homogenate Fractions of Mice under Psycho-Emotional Stress Conditions and upon Afobazole Injection. Eskp. Klin. Farmakol. 2017;80(2):3-7. Russian.","journal-title":"Eskp. Klin. Farmakol."},{"issue":"11","key":"4233_CR2","first-page":"1292","volume":"103","author":"RU Ostrovskaya","year":"2017","unstructured":"Ostrovskaya RU, Antipova TA, Nikolaev SV, Kruglov SV, Ozerova IV, Gudasheva TA, Seredenin SB. Deficit of neurotrophins in experimental diabetes \u2014 correction by proline-containing dipeptide. Ross. Fiziol. Zh. 2017;103(11):1292-1302. Russian.","journal-title":"Ross. Fiziol. Zh."},{"issue":"1","key":"4233_CR3","first-page":"3","volume":"72","author":"SB Seredenin","year":"2009","unstructured":"Seredenin SB, Voronin MV. Neuroreceptor mechanisms involved in the action of Afobazole. Eskp. Klin. Farmakol. 2009;72(1):3-11. Russian.","journal-title":"Eskp. Klin. Farmakol."},{"issue":"3","key":"4233_CR4","first-page":"3","volume":"69","author":"AB Seredenin","year":"2006","unstructured":"Seredenin AB, Melkumyan DS, Val\u2019dman EA, Yarkova MA, Seredenina TS, Voronin MV, Lapitskaya AS. Effects of Afobazole on the BDNF content in brain structures of inbred mice with different phenotypes of emotional stress reaction. Eskp. Klin. Farmakol. 2006;69(3):3-6. Russian.","journal-title":"Eskp. Klin. Farmakol."},{"issue":"2","key":"4233_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1124\/jpet.113.208330","volume":"347","author":"AA Behensky","year":"2013","unstructured":"Behensky AA, Yasny IE, Shuster AM, Seredenin SB, Petrov AV, Cuevas J. Afobazole activation of sigma-1 receptors modulates neuronal responses to amyloid-beta25-35. J. Pharmacol. Exp. Ther. 2013;347(2):468-477.","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2-3","key":"4233_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0014-2999(98)00263-5","volume":"350","author":"SL Chan","year":"1998","unstructured":"Chan SL, Morgan NG. Sigma receptor ligands and imidazoline secretagogues mediate their insulin secretory effects by activating distinct receptor systems in isolated islets. Eur. J. Pharmacol. 1998;350(2-3):267-272.","journal-title":"Eur. J. Pharmacol."},{"key":"4233_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/2823671","volume":"2017","author":"Ceren Eyileten","year":"2017","unstructured":"Eyileten C, Kaplon-Cieslicka A, Mirowska-Guzel D, Malek L, Postula M. Antidiabetic effect of brain-derived neurotrophic factor and its association with inflammation in type 2 diabetes mellitus. J. Diabetes Res. 2017;2017. ID 2823671. doi: \n                    https:\/\/doi.org\/10.1155\/2017\/2823671\n                    \n                  .","journal-title":"Journal of Diabetes Research"},{"key":"4233_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cbi.2015.11.032","volume":"244","author":"SN Goyal","year":"2016","unstructured":"Goyal SN, Reddy NM, Patil KR, Nakhate KT, Ojha S, Patil CR, Agrawal YO. Challenges and issues with streptozotocin-induced diabetes \u2014 a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chem. Biol. Interact. 2016;244:49-63.","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"4233_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jphs.2014.12.005","volume":"127","author":"L Nguyen","year":"2015","unstructured":"Nguyen L, Lucke-Wold BP, Mookerjee SA, Cavendish JZ, Robson MJ, Scandinaro AL, Matsumoto RR. Role of sigma-1 receptors in neurodegenerative diseases. J. Pharmacol. Sci. 2015;127(1):17-29.","journal-title":"J. Pharmacol. Sci."},{"issue":"3","key":"4233_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s10517-014-2562-5","volume":"157","author":"RU Ostrovskaya","year":"2014","unstructured":"Ostrovskaya RU, Zolotov NN, Ozerova IV, Ivanova EA, Kapitsa IG, Taraban KV, Michunskaya AM, Voronina TA, Gudasheva TA, Seredenin SB. Noopept normalizes parameters of the incretin system in rats with experimental diabetes. Bull. Exp. Biol. Med. 2014;157(3):344-349.","journal-title":"Bull. Exp. Biol. Med."},{"issue":"9","key":"4233_CR11","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60(9):1577-1585.","journal-title":"Diabetologia."},{"issue":"4","key":"4233_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","volume":"37","author":"TP Su","year":"2016","unstructured":"Su TP, Su TC, Nakamura Y, Tsai SY. The sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharm. Sci. 2016;37(4):262-278.","journal-title":"Trends Pharm. Sci."},{"key":"4233_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.mam.2015.01.001","volume":"42","author":"J Sun","year":"2015","unstructured":"Sun J, Cui J, He Q, Chen Z, Arvan P, Liu M. Proinsulin misfolding and endoplasmic reticulum stress during the development and progression of diabetes. Mol. Aspects Med. 2015;42:105-118.","journal-title":"Mol. Aspects Med."},{"issue":"6","key":"4233_CR14","doi-asserted-by":"publisher","first-page":"e00273","DOI":"10.1002\/prp2.273","volume":"4","author":"MV Voronin","year":"2016","unstructured":"Voronin MV, Kadnikov IA. Contribution of sigma-1 receptor to cytoprotective effect of Afobazole. Pharmacol. Res. Perspect. 2016;4(6):e00273. doi: \n                    https:\/\/doi.org\/10.1002\/prp2.273\n                    \n                  .","journal-title":"Pharmacol. Res. Perspect."},{"issue":"3","key":"4233_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10517-016-3414-2","volume":"161","author":"VV Zabrodina","year":"2016","unstructured":"Zabrodina VV, Shreder OV, Shreder ED, Durnev AD. Effect of Afobazole and betaine on cognitive disorders in the offspring of rats with streptozotocin-induced diabetes and their relationship with DNA damage. Bull. Exp. Biol. Med. 2016;161(3):359-366.","journal-title":"Bull. Exp. Biol. Med."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10517-018-4233-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-018-4233-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-018-4233-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T23:07:04Z","timestamp":1568675224000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10517-018-4233-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4233"],"URL":"https:\/\/doi.org\/10.1007\/s10517-018-4233-4","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"22 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}